194 related articles for article (PubMed ID: 28586252)
1. Lapachol and lapachone analogs: a journey of two decades of patent research(1997-2016).
Hussain H; Green IR
Expert Opin Ther Pat; 2017 Oct; 27(10):1111-1121. PubMed ID: 28586252
[TBL] [Abstract][Full Text] [Related]
2. A patent review of the therapeutic potential of isoflavones (2012-2016).
Hussain H; Green IR
Expert Opin Ther Pat; 2017 Oct; 27(10):1135-1146. PubMed ID: 28586284
[TBL] [Abstract][Full Text] [Related]
3. Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis.
Pereira EM; Machado Tde B; Leal IC; Jesus DM; Damaso CR; Pinto AV; Giambiagi-deMarval M; Kuster RM; Santos KR
Ann Clin Microbiol Antimicrob; 2006 Mar; 5():5. PubMed ID: 16553949
[TBL] [Abstract][Full Text] [Related]
4. Red Lapacho (Tabebuia impetiginosa)--a global ethnopharmacological commodity?
Gómez Castellanos JR; Prieto JM; Heinrich M
J Ethnopharmacol; 2009 Jan; 121(1):1-13. PubMed ID: 18992801
[TBL] [Abstract][Full Text] [Related]
5. Strategies for Increasing the Solubility and Bioavailability of Anticancer Compounds: β-Lapachone and Other Naphthoquinones.
Ferreira VF; Nicoletti CD; Ferreira PG; Futuro DO; da Silva FC
Curr Pharm Des; 2016; 22(39):5899-5914. PubMed ID: 27291398
[TBL] [Abstract][Full Text] [Related]
6. Shikonin and its derivatives: a patent review.
Wang R; Yin R; Zhou W; Xu D; Li S
Expert Opin Ther Pat; 2012 Sep; 22(9):977-97. PubMed ID: 22834677
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials.
Gong Q; Hu J; Wang P; Li X; Zhang X
Eur J Med Chem; 2021 Jan; 210():112962. PubMed ID: 33158575
[TBL] [Abstract][Full Text] [Related]
8. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1).
Lamberti MJ; Vittar NB; da Silva Fde C; Ferreira VF; Rivarola VA
Phytomedicine; 2013 Aug; 20(11):1007-12. PubMed ID: 23746950
[TBL] [Abstract][Full Text] [Related]
9. Epoxy-α-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2H-naphtho[2,3-b]pyran-10,2'-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites.
Peixoto JF; Oliveira ADS; Gonçalves-Oliveira LF; Souza-Silva F; Alves CR
Braz J Infect Dis; 2023; 27(2):102743. PubMed ID: 36731538
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacins as Anticancer Agents: A Patent Review.
Hussain H; Green IR; Saleem M; Khattak KF; Irshad M; Ali M
Recent Pat Anticancer Drug Discov; 2019; 14(2):133-143. PubMed ID: 30451116
[TBL] [Abstract][Full Text] [Related]
11. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents.
Tandon VK; Kumar S
Expert Opin Ther Pat; 2013 Sep; 23(9):1087-108. PubMed ID: 23651032
[TBL] [Abstract][Full Text] [Related]
12. Semisynthesis and antitumoral activity of 2-acetylfuranonaphthoquinone and other naphthoquinone derivatives from lapachol.
Eyong KO; Kumar PS; Kuete V; Folefoc GN; Nkengfack EA; Baskaran S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5387-90. PubMed ID: 18829316
[TBL] [Abstract][Full Text] [Related]
13. Potential gastroprotective effect of novel cyperenoic acid/quinone derivatives in human cell cultures.
Theoduloz C; Carrión IB; Pertino MW; Valenzuela D; Schmeda-Hirschmann G
Planta Med; 2012 Nov; 78(17):1807-12. PubMed ID: 23047252
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic pyranonaphthoquinones from Melloa quadrival vis (Bignoniaceae).
Lima CS; De Amorim EL; Nascimento SC; De Araújo CF; Agra MF; Barbosa-Filho JM; Silva MS; Da-Cunha EV; Vieira IJ; Braz-Filho R
Nat Prod Res; 2005 Apr; 19(3):217-22. PubMed ID: 15702634
[TBL] [Abstract][Full Text] [Related]
15. β-Lapachone activity in synergy with conventional antimicrobials against methicillin resistant Staphylococcus aureus strains.
Macedo L; Fernandes T; Silveira L; Mesquita A; Franchitti AA; Ximenes EA
Phytomedicine; 2013 Dec; 21(1):25-9. PubMed ID: 24035227
[TBL] [Abstract][Full Text] [Related]
16. Chemical reactivity studies with naphthoquinones from Tabebuia with anti-trypanosomal efficacy.
Pinto CN; Dantas AP; De Moura KC; Emery FS; Polequevitch PF; Pinto MC; de Castro SL; Pinto AV
Arzneimittelforschung; 2000 Dec; 50(12):1120-8. PubMed ID: 11190779
[TBL] [Abstract][Full Text] [Related]
17. Lapachol as an epithelial tumor inhibitor agent in Drosophila melanogaster heterozygote for tumor suppressor gene wts.
Costa WF; Oliveira AB; Nepomuceno JC
Genet Mol Res; 2011 Dec; 10(4):3236-45. PubMed ID: 22194187
[TBL] [Abstract][Full Text] [Related]
18. Monoarylhydrazones of alpha-lapachone: synthesis, chemical properties and antineoplastic activity.
Renou SG; Asís SE; Abasolo MI; Bekerman DG; Bruno AM
Pharmazie; 2003 Oct; 58(10):690-5. PubMed ID: 14609278
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms.
Salas C; Tapia RA; Ciudad K; Armstrong V; Orellana M; Kemmerling U; Ferreira J; Maya JD; Morello A
Bioorg Med Chem; 2008 Jan; 16(2):668-74. PubMed ID: 18029184
[TBL] [Abstract][Full Text] [Related]
20. Quinones derived from plant secondary metabolites as anti-cancer agents.
Lu JJ; Bao JL; Wu GS; Xu WS; Huang MQ; Chen XP; Wang YT
Anticancer Agents Med Chem; 2013 Mar; 13(3):456-63. PubMed ID: 22931417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
